Health Trials

Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry

ConditionsPancreas CancerHepatocellular CarcinomaLung CancerOvarian CancerBreast CancerHead and Neck CancerColon CancerBladder CancerOther Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Oklahoma

About this trial

The purpose of this clinical trial is to evaluate whether volatile organic compound (VOC) signatures detected in the breath of patients with cancer can serve as a potential screening tool for the early detection of cancer.

Eligibility criteria

Qualifiers

Age ≥ 18 at the time of consent. Male and female patients to be tested.

Capable of understanding written and/or spoken English language.

Able to provide informed consent.

Cancer of any type.

Disqualifiers

Under the age of 18.

Anticipated inability to complete breath sampling procedure.

Unable to provide informed consent.

Pregnant women

Trial design

Treatments tested in this trial

  • Proton Transfer Reaction Mass Spectrometry Analysis

Treatment groups

2,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Oklahoma

Lead sponsor

Source ClinicalTrials.gov